Clinical Trial Update: AMG 386 and Abiraterone for Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for AMG 386 combined with Abiraterone in advanced prostate cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• AMG-386 (trebananib)
• Abiraterone (abiraterone)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Prostatic Neoplasms, Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-10-16